WPA
News Stories
Oct 18, 2025

WPA Jean Delay Prize 2026

Nominations are now being sought for the WPA Jean Delay Prize which is psychiatry’s most prestigious award. Conferred triennially by the World Psychiatric Association at its World Congress of Psychiatry, the Prize bears the name of the first president of the WPA and commemorates his own significant contributions to the practice of psychiatry in the 20th century.

Nominations are now being sought for the WPA Jean Delay Prize which is psychiatry’s most prestigious award. Conferred triennially by the World Psychiatric Association at its World Congress of Psychiatry, the Prize bears the name of the first president of the WPA and commemorates his own significant contributions to the practice of psychiatry in the 20th century.

The Prize was first established in 1999 to honour distinguished colleagues who have 1) made a noteworthy contribution to the biological, psychological or social aspects of psychiatry or 2) built useful bridges between them. The prize consists of a diploma.

The award winner is selected by an international jury of experts and is invited to deliver a plenary lecture at the 26th WPA World Congress of Psychiatry in Stockholm, from 23 September to 26 September 2026.

The past awardees are:
1. Professor David Goldberg in 1999
2. Professor Hagop Akiskal in 2002
3. Professor Otto Steenfeldt-Foss in 2005
4. Professor Hans-Jürgen Möller in 2008
5. Professor Kenneth S Kendler in 2011
6. Professor Mitsumoto Sato in 2014
7. Professor Jules Angst in 2017
8. Professor Hannelore Ehrenreich in 2020
9. Professor Robin Murray in 2023

The nomination form can be downloaded here

The closing date for nominations is 6 February 2026.

Please note that applicants must be nominated* and cannot self-nominate. All completed nomination forms should be either posted or emailed to the WPA Secretariat.

*Before making nominations, applicants should consider the following Selection Criteria:
1. Staff of pharmaceutical companies are not eligible for the Prize.
2. Members of the WPA Executive Committee and the Jury of the Jean Delay Prize are not eligible for the Prize.
3. In cases where an individual is nominated for their work on a specific project, that project shall not be related to a pharmaceutical product.
4. A full disclosure will be requested of every applicant, including details of any significant financial interests in any projects related to any nominations made for the Prize.

Author: WPA

Facebook Twitter LinkedIn Copier le lien
view 70